Related Experiment Videos
Endothelin in human autoimmune diseases with renal involvement
1Department of Physiology, University of Munich, Pettenkoferstrasse 12, D-80336 Munich, Germany. Wolfgang.Neuhofer@med.uni-muenchen.de
Rheumatology (Oxford, England)
|September 22, 2006
Summary
Endothelin-1 (ET-1) is implicated in autoimmune kidney diseases. Targeting the ET system may offer therapeutic benefits for human kidney disorders by reducing vasoconstriction and inflammation.
Area of Science:
- Nephrology
- Immunology
- Endocrinology
Background:
- Endothelin-1 (ET-1) is a potent vasoconstrictor with pro-inflammatory, profibrotic, and mitogenic properties.
- Animal studies suggest ET-1 plays a role in the pathogenesis of renal manifestations in autoimmune disorders.
- Human data on ET-1's role in autoimmune kidney diseases are limited.
Purpose of the Study:
- To review and summarize current human observations regarding Endothelin-1 in autoimmune kidney diseases.
- To explore the potential of antagonizing the ET system as a therapeutic strategy for human kidney conditions.
Main Methods:
- Minireview of available human data.
- Analysis of studies reporting ET-1 expression and urinary excretion in human kidney lesions.
- Evaluation of experimental data on ET system antagonism.
Main Results:
- ET-1 is overexpressed in glomerular and tubulointerstitial lesions in human autoimmune kidney diseases.
- Increased urinary excretion of ET-1 reflects its overexpression in kidney lesions.
- Antagonizing the ET system shows beneficial effects in experimental models of kidney disease.
Conclusions:
- ET-1 is a relevant factor in the pathophysiology of human autoimmune kidney diseases.
- Therapeutic strategies targeting the ET system hold promise for treating human kidney diseases.
- ET system antagonism may counteract vasoconstriction, inflammation, and extracellular matrix deposition in autoimmune kidney disease.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...